134 related articles for article (PubMed ID: 2878996)
1. Pharmacological actions of ICI 180080, a novel thromboxane receptor antagonist.
Jessup CL; Jessup R; Wayne M
J Pharm Pharmacol; 1986 Oct; 38(10):754-7. PubMed ID: 2878996
[TBL] [Abstract][Full Text] [Related]
2. Improved synthetic routes to the novel thromboxane receptor antagonist ICI 192605: activity of synthetic 1,3-dioxane intermediates.
Brown GR; Foubister AJ; Hudson JA
J Pharm Pharmacol; 1990 Jan; 42(1):53-5. PubMed ID: 1969951
[TBL] [Abstract][Full Text] [Related]
3. Studies in the guinea-pig with ICI 185,282: a thromboxane A2 receptor antagonist.
Birch J; Brown E; Calnan C; Jessup CL; Jessup R; Wayne M
J Pharm Pharmacol; 1988 Oct; 40(10):706-10. PubMed ID: 2907537
[TBL] [Abstract][Full Text] [Related]
4. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
Lumley P; White BP; Humphrey PP
Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
Yu SM; Wu TS; Teng CM
Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
[TBL] [Abstract][Full Text] [Related]
6. ICI 180080, a novel selective thromboxane receptor antagonist: synthesis and relative activity.
Brown GR; Foubister AJ
J Pharm Pharmacol; 1986 Sep; 38(9):706-8. PubMed ID: 2877076
[TBL] [Abstract][Full Text] [Related]
7. The synthesis of a novel thromboxane receptor antagonist 4(Z)-6-(2-o-chlorophenyl-4-o-hydroxyphenyl-1,3-dioxan-cis-5-yl) hexenoic acid ICI 192605.
Brewster AG; Brown GR; Foubister AJ; Jessup R; Smithers MJ
Prostaglandins; 1988 Aug; 36(2):173-8. PubMed ID: 2973084
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.
Ogletree ML; Harris DN; Schumacher WA; Webb ML; Misra RN
J Pharmacol Exp Ther; 1993 Feb; 264(2):570-8. PubMed ID: 8437108
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.
Tymkewycz PM; Jones RL; Wilson NH; Marr CG
Br J Pharmacol; 1991 Mar; 102(3):607-14. PubMed ID: 1364826
[TBL] [Abstract][Full Text] [Related]
10. Cinnamophilin, a novel thromboxane A2 receptor antagonist, isolated from Cinnamomum philippinense.
Yu SM; Ko FN; Wu TS; Lee JY; Teng CM
Eur J Pharmacol; 1994 Apr; 256(1):85-91. PubMed ID: 8026563
[TBL] [Abstract][Full Text] [Related]
11. ZD1542, a potent thromboxane A2 synthase inhibitor and receptor antagonist in vitro.
Brownlie RP; Brownrigg NJ; Butcher HM; Garcia R; Jessup R; Lee VJ; Tunstall S; Wayne MG
Br J Pharmacol; 1993 Dec; 110(4):1600-6. PubMed ID: 8306107
[TBL] [Abstract][Full Text] [Related]
12. Antagonistic action of AA-2414 on thromboxane A2/prostaglandin endoperoxide receptor in platelets and blood vessels.
Imura Y; Terashita Z; Shibouta Y; Inada Y; Nishikawa K
Jpn J Pharmacol; 1990 Jan; 52(1):35-43. PubMed ID: 2137886
[TBL] [Abstract][Full Text] [Related]
13. Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.
Karasawa A; Shirakura S; Higo K; Kubo K
Arzneimittelforschung; 1991 Dec; 41(12):1237-41. PubMed ID: 1815522
[TBL] [Abstract][Full Text] [Related]
14. L-641,953 (R-8-fluoro-dibenzo[b, f]thiepin-3-carboxylic acid-5-oxide): a novel thromboxane-prostaglandin endoperoxide antagonist.
Hall RA; Rokach JR; Bélanger P; Bianchi L; Ethier D; Ford-Hutchinson AW; Girard Y; Hamel P; Hamel R; Lord A
Can J Physiol Pharmacol; 1987 Apr; 65(4):509-14. PubMed ID: 3607600
[TBL] [Abstract][Full Text] [Related]
15. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
[TBL] [Abstract][Full Text] [Related]
16. (5Z)-7-(2,2-Dimethyl-4-phenyl-1,3-dioxan-cis-5-yl)heptenoi c acid: a specific thromboxane A2 receptor antagonist.
Brewster AG; Caulkett PW; Jessup R
J Med Chem; 1987 Jan; 30(1):67-70. PubMed ID: 2949077
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM
J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833
[TBL] [Abstract][Full Text] [Related]
18. The thromboxane A2/prostaglandin endoperoxide receptor antagonist activity of CV-4151, a thromboxane A2 synthetase inhibitor.
Imura Y; Terashita Z; Shibouta Y; Nishikawa K
Eur J Pharmacol; 1988 Mar; 147(3):359-65. PubMed ID: 2967770
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist.
Ogletree ML; Harris DN; Greenberg R; Haslanger MF; Nakane M
J Pharmacol Exp Ther; 1985 Aug; 234(2):435-41. PubMed ID: 3926986
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H
Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
